Prognosis of sudden deafness remains a challenge in clinics due to inhomogeneity of the disease. Here we report our retrospective study aimed to explore the value of coagulative markers including activated partial thromboplastin time (APTT), prothrombin time (PT), plasma fibrinogen (FIB) and plasma D-Dimer in the prognosis of the patients. The study included a total of 160 patients, of which 92 had valid responses, and 68 had invalid responses and 68 had ineffective responses. APTT, PT, and the levels of FIB and D-D in serum were compared between the two groups, and their prognostic values were determined in terms of area-under-curve (AUC) in receiver operating curve (ROC) analysis, sensitivity and specificity. The correlations of APTT, PT and FIB to hearing loss degree were also assessed. Serum APTT and PT, FIB and D-Dimer levels were lower in patients with sudden deafness that responded poorly to treatments. ROC analysis showed that APTT, PT, FIB and D-Dimer had high AUC, sensitivity and specificity for non-responders, particularly when used in combination (AUC=0.91, sensitivity=86.76%, and specificity=82.61%). Patients with a higher hearing loss degree (>91dB) also demonstrated significantly lower values of APTT and PT and higher levels of serum FIB and D-Dimer than those with a lower hearing loss degree. Our study demonstrated that APTT, PT, and serum levels of FIB and D-D could serve as strong predictors of sudden deafness, potentiating the use of these tests to identify patients that respond poorly to treatments.